Today, we released our fiscal year 2026 & Q4 results that validate our global medical cannabis strategy, which has positioned us a leading provider around the world.
For the complete press release and financial disclosures, visit here: https://t.co/XhCO6EC8qR
Pour diversifier le commerce international du Canada, il faut investir dans des secteurs en forte croissance offrant des produits prêts à l’exportation, comme le cannabis médical.
What Canada Owes Its Veterans: Getting Medical Cannabis Reimbursement Right, @savoner writes https://t.co/uClBjpzsfL #nationlnewswatch via @natnewswatch
Today, we released our FY26 Q1 financial results, reinforcing our continued leadership in the global cannabis industry.
For the complete press release and financial disclosers, visit here: https://t.co/iD57Oha5xo
We’re excited to welcome Rick Savone, SVP of Global Gov’t Relations at Aurora Cannabis, as a keynote speaker at #ACannabis! In “Be Careful What You Wish For,” he’ll dive into how legalisation policies are shaping the industry's future. Register at https://t.co/MPRJbVy9JI
Today, we released our FY25Q4 & Full Fiscal 2025 results, showcasing our continued leadership in the global cannabis industry.
For the complete press release and financial disclosers, visit here: https://t.co/s68S2LH7fy
Today, we released our Q3 Fiscal 2025 results, showcasing our continued leadership in the cannabis industry.
For the complete press release and financial disclosers, visit here: https://t.co/mTSKSvpFt1
Complexity, cost, and inefficiency—these are just a few of the challenges licensed producers face with the current excise stamp system. But there’s a better way. Watch this video to learn more: https://t.co/2W4HKOgDaE
C3's 2025 Excise Survey results are in, and they are staggering. The need for reform has never been more clear – we need to adjust excise taxation now. Register for the Canadian Cannabis Leadership Summit to join the conversation: https://t.co/zS7xmuFWsQ
Something must change for Canadian cannabis to move forward. C3 invites you to an afternoon of insightful discussion about the key challenges facing the industry. Reserve your spot at the Canadian Cannabis Leadership Summit on Oct 1: https://t.co/zS7xmuFWsQ
C3 is pleased to announce Tamara Lovi as the new Chair of our Board of Directors. Lovi, who has been a member of the Board for 2 years, brings a wealth of experience and leadership to the role.
Read the release: https://t.co/wudWMwxhNk
It's time to fix what’s broken.
The excise tax must be lowered to give producers a fair shot at making legalization a true success. Read more @nationalpost: Trudeau’s signature pot legalization is failing on all fronts
#ExciseTaxReform#CannabisIndustry
https://t.co/GNdbqyGn78
Today we released our Q4 FY24 Results:
- Record annual Adjusted EBITDA of $12.8M
- Quarterly net revenue up 5% YoY to $67.4M
- Global medical cannabis revenue grew 20% YoY to $45.6M
- Ended FY24 with ~$180M cash, debt-free
🔗 Full update: https://t.co/kmrUQohf5R
We're thrilled to share that our first shipment of medical cannabis has reached the New Zealand market! This marks a significant milestone in our mission of #OpeningTheWorldToCannabis.
Read more about this in our press release: [https://t.co/3FKSduuuVO]
This year's federal budget overlooks crucial reforms in the cannabis sector's tax & regulatory framework, despite clear evidence from the Finance Committee, Competition Bureau and Cannabis Act Review that the industry faces significant financial stress and needs urgent change.